Wipfli Financial Advisors’s AtriCure ATRC Stock Holding History

Wipfli Financial Advisors’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$3K	Buy	+80	New	+$3.66K	﹤0.01%	2189

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Wipfli Financial Advisors's ATRC Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in AtriCure (ATRC) in Q3 2022: 80 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #2189 among its holdings.

214 funds tracked by Wall St. Rank hold ATRC as of Q3 2022.

Wipfli Financial Advisors held 80 shares of AtriCure worth $3K as of Q3 2022.
AtriCure was a new Wipfli Financial Advisors position in Q3 2022.
AtriCure made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2189 holding.
214 funds tracked by Wall St. Rank held AtriCure as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.